Skip to content

A Retrospective Study on the Safety and Efficacy of One-stage Robot-assisted Laparoscopic Partial Nephrectomy Combined with Ipsilateral Adrenal Tumor Resection

A Retrospective Study on the Safety and Efficacy of One-stage Robot-assisted Laparoscopic Partial Nephrectomy Combined with Ipsilateral Adrenal Tumor Resection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128908
Enrollment
Unknown
Registered
2026-07-28
Start date
2026-07-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cancer andadrenal tumor

Interventions

Robotic-assisted combined partial nephrectomy and adrenal tumorectomy group:none

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Age ranging from 18 to 85 years without gender restriction; patients diagnosed with unilateral renal tumor accompanied by ipsilateral adrenal tumor via computed tomography (CT) or magnetic resonance imaging (MRI). 2.Clinical stage eligible for partial nephrectomy (cT1–T2 renal tumors); adrenal tumors meeting surgical indications (adenoma, pheochromocytoma). 3.Receipt of one-stage combined robotic-assisted laparoscopic partial nephrectomy plus ipsilateral adrenal tumorectomy. 4.Complete clinical, perioperative, pathological and follow-up data available.

Exclusion criteria

Exclusion criteria: 1.Patients requiring radical nephrectomy instead of partial nephrectomy. 2.Patients with advanced stage/grade disease (renal tumor = cT3, extensively invasive malignant adrenal tumors) unsuitable for safe simultaneous resection. 3.Suspected malignant adrenal tumors. 4.Patients with severe cardiac, pulmonary, hepatic or renal dysfunction intolerant to anesthesia and surgery. 5.Presence of high-risk factors including coagulation disorders, active hemorrhage, and uncontrolled infection. 6.Patients with severely missing clinical data, loss to follow-up, or unavailable efficacy evaluation. 7.Patients with prior surgical history on the ipsilateral kidney or adrenal gland that interferes with outcome assessment.

Design outcomes

Primary

MeasureTime frame
Estimated blood loss;Postoperative complications;Warm Ischemia Time;renal function;operation time;Postoperative hospital stay;

Secondary

MeasureTime frame
Pathological findings;postoperative followup;Surgical approach;basic data of the patients;

Countries

China

Contacts

Public ContactChen Gang

The First Affiliated Hospital of Chongqing Medical University

280966796@qq.com+86 23 8901 2919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026